Page 2 - Managing Advanced Urothelial Carcinoma in 2020: Canadian Consensus Updates
P. 2
Presenter Disclosure
Aly-Khan Lalani
Company/ Details
Organization
I have received a grant(s) or an honorarium from a AbbVie, Astellas, BMS, Eisai, Ipsen, Honoraria
commercial organization. Janssen, Merck, Novartis, Pfizer,
Roche, TerSera, CUA
Novartis, Roche, Ipsen, EMD Serrono Research grants, all funds paid to HHS
I am currently participating in or have participated in a BMS, Merck All funds paid to HHS
clinical trial within the past two years.